Organigram Global Inc.

OGI • Drug Manufacturers - Specialty & Generic

$1.16

— 0.00 (0.00%)

ResultadosÚltimo reporte: 31 mar 2026

PERFIL DE MAYOR RIESGOPrecauciónConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Conviene actuar con cautela. Los ratios recientes muestran debilidades que pueden limitar el retorno si los fundamentales no mejoran.

Capitalización

$151.96M

Crecimiento

—

Flujo de caja

0/5

Tendencia

Negative

Evidencia

Nivel de deuda manejable · 0.03Liquidez saludable · 2.26Rentabilidad débil

Datos financieros hasta: 31 mar 2026, 12:00 a.m. UTCÚltima actualización de earnings: 12 may 2026, 12:00 a.m. UTCÚltima actualización del perfil: 13 ago 2026, 12:51 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$1.16

Change0.00%

Shares Out131.57M

Market Cap$151.96M

52W Range0.85 - 2.24

Beta1.85

P/E-59.62

P/S3.67

P/B0.59

P/FCF-33.58

EV/Sales3.34

EV/EBITDA-41.90

Price$1.16

Change0.00%

Shares Out131.57M

Market Cap$151.96M

52W Range0.85 - 2.24

Beta1.85

P/E-59.62

P/S3.67

P/B0.59

P/FCF-33.58

EV/Sales3.34

EV/EBITDA-41.90

EV/FCF-30.49

Earnings Yield-0.42%

FCF Yield-2.98%

Dividend Yield0.00%

Gross Margin3.67%

Oper. Margin-34.07%

Profit Margin-9.55%

Debt/Eq0.03

Current Ratio2.26

Quick Ratio1.28

Volume2.36M

Avg Volume596.91K

EPS Surprise0.00

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

22/100

Fortaleza financiera

Deuda, caja, estabilidad

73/100

Potencial de crecimiento

Ingresos y expansión

62/100

Atractivo del precio

Barata o cara hoy

91/100

Por qué este puntaje▼

Nivel de deuda manejable · 0.03Liquidez saludable · 2.26Rentabilidad débil

Analyst view

Analyst sentiment and price target

OGI

Analyst sentiment

Based on 5 analyst votes · 2026-09-05

60/100

Neutral

Bullish

Hold

Bearish

Resumen de la compañía

IPO: 5/21/2019

Industria: Drug Manufacturers - Specialty & Generic

P/B i: 0.59

Deuda / Patrimonio i: 0.03

Margen operativo: -34.07%

Margen neto: -9.55%

ROE i: -

ROIC: -

Salud financiera

Puntaje15 / 20

Deuda / Patrimonio: 0.03

Ratio corriente: 2.26

Ratio rápido: 1.28

Estado: Good

🧾

No hay actividad interna

No hay transacciones internas recientes disponibles.

Sobre la compañía

Organigram Global Inc.

Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.

Fuente - Link

Competidores

ACB DERM ELMD HSDT INFU IVA LFCR OBIO RNAC SXTC

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Organigram Global to Host 2026 OG Investor Session

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session. “Since our last investor session, we've welcomed a new leadership team, completed our first full quarter with Sanity Group, and sharpened our strategy for the years ahead. We look forward to updating our stakeholders on how we're aligning Organigram.

Business Wire

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (âOrganigramâ or the âCompanyâ) today announced an important milestone in its global growth strategy thr

GuruFocus

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Company”) today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH (“Sanity”) and the alignment of leadership, operations and market development activities across the combined organization. To support the combined organization, Organigram has appointed Finn Age Hänsel as President, Rest of World & Chief Strategy Officer, and Adr.

Business Wire

OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates

OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.03 per share a year ago.

Zacks Investment Research

Organigram Global Q3 Earnings Call Highlights

Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, aided by the consolidation of Germany-based Sanity Group and improving performance in several Canadian cannabis categories.

MarketBeat

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-12	-0.01	-0.01	0
2026-02-10	-0.01	-0.02	-0.01
2025-12-16	-0.00481	-0.2	-0.19519
2025-08-13	-0.01	-0.03	-0.02
2025-05-12	-0.03	-0.05	-0.02
2025-02-11	-0.03	-0.05	-0.02
2024-12-18	-0.03	-0.04	-0.01
2024-08-13	-0.05	0.02	0.07
2024-05-14	-0.06	-0.12	-0.06
2024-02-13	-0.1	-0.14	-0.04
2023-12-19	-0.14	-0.04	0.1
2023-07-13	-0.05	-0.15	-0.1